Paternal postpartum depression in an obsessive personality following the COVID-19 lockdown successfully treated with Vortioxetine
Introduction A growing amount of studies investigating the mental health impact of the current COVID-19 pandemic worldwide have been recently published, even though very few studies investigating the impact of the COVID-19 outbreak and lockdown on the mental health of fathers of newborns during the...
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Cambridge University Press
2022-06-01
|
Colecção: | European Psychiatry |
Assuntos: | |
Acesso em linha: | https://www.cambridge.org/core/product/identifier/S0924933822012913/type/journal_article |
Resumo: | Introduction
A growing amount of studies investigating the mental health impact of the current COVID-19 pandemic worldwide have been recently published, even though very few studies investigating the impact of the COVID-19 outbreak and lockdown on the mental health of fathers of newborns during the COVID-19 pandemic, particularly on paternal postpartum depression (PPD).
Objectives
A case report describing a 37-years-old man with an obsessive-compulsive personality who manifests the onset of a clinically relevant PPD following his wife’s delivery during the COVID-19 pandemic and the onset of obsessive symptomatology.
Methods
At baseline and during a 12-months follow-up were administered the Edinburgh Postnatal Depression Scale (EPDS), Fear of COVID-19 (FCV-19-S), Coronavirus Anxiety Scale (CAS) and Y-BOCS-II (Yale-Brown Obsessive Compulsive Scale).
Results
Patient was successfully treated with vortioxetine up to 20 mg/die with a significant clinical remission of depressive and obsessive symptomatology at 6 months and a maintenance therapy with vortioxetine 10 mg daily.
Conclusions
PPD should be better investigated, particularly the impact of COVID-19 pandemic on mental health of fathers of newborns during the COVID-19-related situation.
Disclosure
No significant relationships.
|
---|---|
ISSN: | 0924-9338 1778-3585 |